$ANTH..$3.07.. On 6/28 Anthera provides clinical program updates: "Positive trends from BRIGHT-SC Proof-Of-Concept Study..Study to Continue. -Anthera says "CHABLIS-SC1 results to be reported in the third quarter (Q3). Recent DSMB review found no safety issues. investorshub.advfn.com/uimage/uploads/2016/6/27/sfxkpimage.jpg